With A Possibility For CRISPR To Cure “All” Diseases, Should All New Biotech Companies Be Designated Public Benefit Corporations (PBCs) To Thwart Potentially Specious Big Pharma Takeovers?

March 23, 2020

With A Possibility For CRISPR To Cure “All” Diseases, Should All New Biotech Companies Be Designated Public Benefit Corporations (PBCs) To Thwart Potentially Specious Big Pharma Takeovers?

A neoteric philosophy on CRISPR (Cas9 and other variants): biotech startups; takeovers; Big Pharma (potentially comprised with executives susceptible to unscrupulous …

Forget Jobs, Bezos, Gates or Musk, It’s Time The World Knows The Name Rothblatt

October 24, 2019

Forget Jobs, Bezos, Gates or Musk, It’s Time The World Knows And Echoes The Name Rothblatt: Elevate Talk And Post-talk Interview

photo credit: Laura Miller

February 7, 2019

ProteinQure, AI and the Future of Drug Design

Protein Origami CRISPR is all the rage these days in the Biosciences, for its ability to edit DNA and to …

cure